Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
<p><strong>Background</strong></p> <p>Radiotherapy enhances innate and adaptive anti-tumour immunity. It is unclear whether this effect may be harnessed by combining immunotherapy with radiotherapy fractions used to treat prostate cancer. We investigated tumour immune m...
Main Authors: | Philippou, Y, Sjoberg, HT, Murphy, E, Alyacoubi, S, Jones, KI, Gordon-Weeks, AN, Phyu, S, Parkes, EE, McKenna, WG, Lamb, AD, Gileadi, U, Cerundolo, V, Scheiblin, DA, Lockett, SL, Wink, DA, Mills, IG, Hamdy, FC, Muschel, RJ, Bryant, RJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2020
|
Similar Items
-
Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models
by: Y Philippou, et al.
Published: (2020-07-01) -
Harnessing the potential of multimodal radiotherapy in prostate cancer
by: Philippou, Y, et al.
Published: (2020) -
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
by: Charlton, P, et al.
Published: (2023) -
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
by: Charlton, PV, et al.
Published: (2024) -
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types
by: Rao, SR, et al.
Published: (2023)